SELLAS Life Sciences Group
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$37,340,000 over the previous period. Total operating expenses were $37,869,000.

Profit Margin

SELLAS Life Sciences Group, Inc. (NASDAQ:SLS): Profit margin
2014 9.31M -36.60M -392.81%
2015 0 -63.90M
2016 0 -23.54M
2017 0 -23.75M
2018 0 -27.67M
2019 0 -19.29M
2020 1.9M -16.75M -881.95%
2021 7.6M -20.69M -272.36%
2022 1M -40.65M -4065.2%
2023 0 -37.34M

SLS Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
01M7.6M1.9M000009.31M
Cost of revenue
0100K200K00000355K1.40M
Gross profit
0900K7.4M1.9M0000-355K7.91M
Operating exp.
Research and development
24.00M30.26M21.37M9.28M7.28M18.31M6.06M19.86M23.61M28.35M
Selling and marketing
0000000000
Total operating expenses
37.86M42.85M32.69M18.88M17.20M31.08M21.15M31.86M34.22M60.13M
Operating income
-37.86M-41.95M-25.29M-16.98M-20.04M-31.08M-23.03M-31.86M-34.22M-52.22M
Other income (expenses), net
529K649K4.35M208K668K2.30M-7.78M24.51M-4.37M13.61M
Income before tax
-37.34M-41.30M-20.93M-16.77M-19.37M-29.04M-23.50M-10.85M-38.59M-36.60M
Income tax expense
0-649K-237K-17K-81K-1.37M253K243K365K-15.44M
Net income
-37.34M-40.65M-20.69M-16.75M-19.29M-27.67M-23.75M-23.54M-63.90M-36.60M
Earnings per share
Basic EPS
-1.34-2.1-1.34-2.1-7.54-105.8-507.49-3.54K-12.34K-9.19K
Diluted EPS
-1.34-2.1-1.34-2.1-7.54-105.8-507.49-3.54K-12.34K-9.19K
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source